These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3950112)

  • 1. Topical application of nonsteroidal anti-inflammatory drugs prevents vehicle-induced improvement of psoriasis.
    Ellis CN; Fallon JD; Kang S; Vanderveen EE; Voorhees JJ
    J Am Acad Dermatol; 1986 Jan; 14(1):39-43. PubMed ID: 3950112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral meclofenamate therapy in psoriasis.
    Ellis CN; Goldfarb MT; Roenigk HH; Rosenbaum M; Wheeler S; Voorhees JJ
    J Am Acad Dermatol; 1986 Jan; 14(1):49-52. PubMed ID: 3512633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meclofenamate for psoriasis.
    Paller AS; Wishner A; Roenigk HH
    Arch Dermatol; 1984 Apr; 120(4):438. PubMed ID: 6367669
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombocytopenia associated with meclofenamate.
    Rodriguez J
    Drug Intell Clin Pharm; 1981 Dec; 15(12):999. PubMed ID: 7338199
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe, reversible thrombocytopenia associated with meclofenamate.
    Schimizzi GF; Graehl PM; Michalski JP
    Arthritis Rheum; 1982 Mar; 25(3):359-60. PubMed ID: 7066066
    [No Abstract]   [Full Text] [Related]  

  • 6. Meclofenamate sodium-induced agranulocytosis and suppression of erythropoiesis.
    Wishner AJ; Milburn PB
    J Am Acad Dermatol; 1985 Dec; 13(6):1052-3. PubMed ID: 4078095
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum 13-14-diOH-15-keto-prostaglandin F2 alpha and airway response to meclofenamate and metaproterenol in relation to the menstrual cycle.
    Eliasson O; Longo M; Dore-Duffy P; Densmore MJ; DeGraff AC
    J Asthma; 1986; 23(6):309-19. PubMed ID: 3546255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily treatment of psoriasis with topical glucocorticosteroid ointments.
    Lane AT; Wachs GN; Weston WL
    J Am Acad Dermatol; 1983 Apr; 8(4):523-5. PubMed ID: 6853785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sodium meclofenamate and indomethacin in rheumatoid arthritis.
    Rennie JA; MacLeod MM; Reynolds PN; El-Ghobarey AF
    Curr Med Res Opin; 1977; 4(8):580-3. PubMed ID: 326493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meclofenamate (Meclomen) therapy of psoriasis.
    Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1983 May; 8(5):759-60. PubMed ID: 6863641
    [No Abstract]   [Full Text] [Related]  

  • 11. Indomethacin and meclofenamate potentiation of skeletal muscle active hyperemia.
    Rankin RS; Klabunde RE
    Life Sci; 1985 Jan; 36(2):161-8. PubMed ID: 3917524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind multicenter study comparing meclofenamate sodium with indomethacin and placebo in the treatment of extra-articular rheumatic disease.
    Boussina I; Günthner W; Martí Massó R
    Arzneimittelforschung; 1983; 33(4A):649-52. PubMed ID: 6349650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to anthranilic acid derivatives.
    Fernandez-Rivas M; de la Hoz B; Cuevas M; Davila I; Quirce S; Losada E
    Ann Allergy; 1993 Dec; 71(6):515-8. PubMed ID: 7903514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European double-blind multicenter study comparing meclofenamate sodium and indomethacin in the treatment of rheumatoid arthritis.
    Dunky A; Mattern H
    Arzneimittelforschung; 1983; 33(4A):636-40. PubMed ID: 6349647
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
    Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH
    Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meclofenamate sodium in the treatment of ankylosing spondylitis. Report of a European double-blind controlled multicenter study.
    Ebner W; Poal Ballarin JM; Boussina I
    Arzneimittelforschung; 1983; 33(4A):660-3. PubMed ID: 6349653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of arachidonic acid in psoriasis.
    Wilkinson DI
    Cutis; 1984 Apr; 33(4):353, 358. PubMed ID: 6426865
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of psoriasis to a new topical retinoid, AGN 190168.
    Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M
    J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
    Langner A; Verjans H; Stapór V; Mol M; Fraczykowska M
    Br J Dermatol; 1993 May; 128(5):566-71. PubMed ID: 8504051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
    Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
    J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.